U.S. stock futures mixed, Nasdaq 100 up 0.1%. Coty Inc (COTY) shares down 7.7% after reporting losse

Cramer recommends buying Carpenter Technology (NYSE: CRS) and calls DXC Technology (NYSE: DXC) a val

Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session.

Senseonics Holdings (AMEX:SENS) raises FY2026 sales outlook from $60.000 million-$64.000 million to

Senseonics Holdings (AMEX:SENS) reported quarterly losses of $(0.63) per share which met the analyst

Mizuho analyst Anthony Petrone maintains Senseonics Holdings (NASDAQ:SENS) with a Outperform and

Senseonics, a medical technology company focused on implantable Continuous Glucose Monitoring (CGM)

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, valid

HC Wainwright & Co. analyst Sean Lee maintains Senseonics Holdings (NASDAQ:SENS) with a Buy a

Stifel analyst Jonathan Block maintains Senseonics Holdings (NASDAQ:SENS) with a Hold and lowers

Senseonics Holdings (AMEX:SENS) raises FY2026 sales outlook from $58.000 million-$62.000 million to

Senseonics Holdings (AMEX:SENS) reported quarterly losses of $(0.71) per share which missed the anal

Shares of Senseonics Holdings Inc (NASDAQ:SENS) are tumbling Friday morning pricing an $80 million u

Twilio Inc (NYSE: TWLO) reported strong Q1 results and raised future sales guidance above estimates,

Senseonics Holdings, Inc. (NASDAQ:SENS), a medical technology company focused on the development, ma

GlucoTrack targets a Q2 2026 FDA IDE filing for CGM, backed by clinical data, manufacturing strategy

https://www.sec.gov/Archives/edgar/data/1616543/0001270735-26-000004-index.html

Senseonics Holdings (AMEX:SENS) sees FY2026 sales of $58.000 million-$62.000 million vs $58.832 mill

Senseonics Holdings (AMEX:SENS) reported quarterly losses of $(0.46) per share which missed the anal

Sequel Med Tech, LLC, a company developing transformative drug delivery technologies, and Senseonics

Senseonics Holdings, Inc. (NASDAQ:SENS) a medical technology company focused on the development and

HC Wainwright & Co. analyst Sean Lee maintains Senseonics Holdings (AMEX:SENS) with a Buy and

Senseonics Holdings (AMEX:SENS) narrows FY2025 sales outlook from $34.000 million-$38.000 million to

Senseonics Holdings (AMEX:SENS) reported quarterly losses of $(0.43) per share which missed the anal

TD Cowen analyst Joshua Jennings maintains Senseonics Holdings (AMEX:SENS) with a Buy and lowers

Stifel analyst Jonathan Block reinstates Senseonics Holdings (AMEX:SENS) with a Hold and announce

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001616543/000110465925100097/tm2528782d1_8k.htm

Benzinga examined the prospects for many investors' favorite stocks over the last week — here&#3

Senseonics stock drops on reverse split announcement despite record U.S. patient growth and 91% jump

Preliminary unaudited revenue of $8.1 million for Q3 2025Generated record quarterly new patient star

Senseonics continues to expect full-year 2025 global net revenue to be approximately $34-38 million

CGM commercial operations to transition from Ascensia Diabetes Care to SenseonicsBrian Hansen to be

Barclays analyst Matt Miksic initiates coverage on Senseonics Holdings (AMEX:SENS) with a Overwei

Senseonics Holdings (AMEX:SENS) affirms FY2025 sales outlook from $34.000 million-$38.000 million to

Senseonics Holdings (AMEX:SENS) reported quarterly losses of $(0.02) per share which met the analyst

TD Cowen analyst Joshua Jennings initiates coverage on Senseonics Holdings (AMEX:SENS) with a Buy

HC Wainwright & Co. analyst Sean Lee maintains Senseonics Holdings (AMEX:SENS) with a Buy and

https://x.com/SarahKarlin/status/1937539272392733011 

HC Wainwright & Co. analyst Sean Lee assumes Senseonics Holdings (AMEX:SENS) with a Buy ratin

Senseonics Holdings (AMEX:SENS) affirms FY2025 sales outlook from $34.00 million-$38.00 million to $